Ian S. Hagemann

Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells

Andrea Facciabene, Xiaohui Peng, Ian S. Hagemann et al. · Nature · 2011 · 1.4K citations

Medicine, Cancer Biology, Oncology +14

Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors

Gregory T. Motz, Stephen P. Santoro, Liping Wang et al. · Nature Medicine · 2014 · 1K citations · Full text

Medicine, Immunology, Oncology +14

Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial

Ravindra Uppaluri, Katie M. Campbell, Ann Marie Egloff et al. · Clinical Cancer Research · 2020 · 365 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Clinical next‐generation sequencing in patients with non–small cell lung cancer

Ian S. Hagemann, Siddhartha Devarakonda, Christina M. Lockwood et al. · Cancer · 2014 · 240 citations

Medicine, Molecular Genetics, Oncology +17

Redirected Antitumor Activity of Primary Human Lymphocytes Transduced With a Fully Human Anti-mesothelin Chimeric Receptor

Evripidis Lanitis, Mathilde Poussin, Ian S. Hagemann et al. · Molecular Therapy · 2011 · 189 citations · Full text

Life Sciences, Immunology, Oncology +17